Literature DB >> 10426275

NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice.

R S Abraham1, S B Wilson, N F de Souza, J L Strominger, S R Munn, C S David.   

Abstract

The major histocompatibility complex (MHC) genes play a significant role in the predisposition to insulin-dependent diabetes mellitus or type 1 diabetes. HLA-DQ8 (DQB1*0302, DQA 1*0301) genes have been shown to have the highest relative risk for human type 1 diabetes. To develop a "humanized" mouse model of diabetes, HLA-DQ8 was transgenically expressed in mice lacking endogenous class II genes. Since non-MHC background genes of the NOD influence the disease process, AP"/DQ8 mice were mated with the NOD strain and backcrossed to generate Abeta degree/DQ8/NOD mice. These mice have DQ8 as the sole MHC class II restriction element with NOD background genes at the N 2 generation. The DQ8 transgenic mice were used to identify T cell epitopes on glutamic acid decarboxylase (GAD 65), an important putative autoantigen in type 1 diabetes. The NOD background genes strongly influenced antigen processing, that is, different T cell epitopes were generated from the processing of GAD 65 in vivo in the Abeta degree/DQ8 and in the Abeta degree/DQ8/NOD mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426275     DOI: 10.1016/s0198-8859(99)00057-9

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

1.  Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.

Authors:  Huan Yang; Elzbieta Goluszko; Chella David; David K Okita; Bianca Conti-Fine; Teh-sheng Chan; Mathilde A Poussin; Premkumar Christadoss
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice.

Authors:  J C Flynn; C Meroueh; D P Snower; C S David; Y M Kong
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

3.  Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice.

Authors:  Raya B Elagin; Sadguna Balijepalli; Maria J Diacovo; Steinunn Baekkeskov; Juan C Jaume
Journal:  J Autoimmun       Date:  2009-03-16       Impact factor: 7.094

Review 4.  What can the HLA transgenic mouse tell us about autoimmune diabetes?

Authors:  F S Wong; L Wen
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

5.  Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice.

Authors:  John A Gebe; Kellee A Unrath; Betty B Yue; Tom Miyake; Ben A Falk; Gerald T Nepom
Journal:  J Autoimmun       Date:  2007-10-18       Impact factor: 7.094

6.  FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice.

Authors:  Ferenc Boldizsar; Oktavia Tarjanyi; Katalin Olasz; Akos Hegyi; Katalin Mikecz; Tibor T Glant; Tibor A Rauch
Journal:  Cardiovasc Pathol       Date:  2016-05-17       Impact factor: 2.185

Review 7.  T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives.

Authors:  Roberto Mallone; Vedran Brezar; Christian Boitard
Journal:  Clin Dev Immunol       Date:  2011-07-19

Review 8.  Preclinical Models to Evaluate the Human Response to Autoantigen and Antigen-Specific Immunotherapy in Human Type 1 Diabetes.

Authors:  Pamela Houeiss; Christian Boitard; Sandrine Luce
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-13       Impact factor: 6.055

9.  Prediction of HLA-DQ8beta cell peptidome using a computational program and its relationship to autoreactive T cells.

Authors:  Kuan Y Chang; Emil R Unanue
Journal:  Int Immunol       Date:  2009-05-21       Impact factor: 4.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.